Salvage radiotherapy for prostate cancer recurrence after surgery
Part of Cancer, Kidney & urinary clinical trials.
This study tests a very short course of radiation given after prostate surgery, specifically for men whose PSA is rising again. The goal is to see if this approach can safely control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man 18 or older
- You had surgery to remove your prostate
- Your PSA is between 0.1 and 2.0 ng/mL (a sign the cancer may be returning)
- A PSMA PET scan within 90 days shows no spread to lymph nodes or other parts of the body
- You never had radiation to the prostate or pelvis before, or brachytherapy
- You do not have active inflammatory bowel disease or take drugs that suppress your immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two schedules of pelvic radiotherapy for men whose prostate cancer has returned after surgery. Both schedules aim to control the cancer with fewer visits for one of them.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests giving early salvage radiotherapy (a type of radiation) to men whose PSA rises after prostate removal, but before it shows up on scans. It aims to see if starting treatment early, based on molecular markers, is more effective than waiting.
This trial tests how well salvage radiation therapy works for prostate cancer that has come back after surgery. It looks at whether adding hormone therapy based on PSA response improves outcomes.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
Hear when a new Prostate Cancer (Post Prostatectomy) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.